AZACITIDINE

NDC 55150-393 · Eugia US LLC

Generic nameAZACITIDINE

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)AZACITIDINE

Strength100 mg/4mL

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]

Marketing categoryANDA

Packages

55150-393-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-393-01) / 4 mL in 1 VIAL, SINGLE-DOSE

J9025 — Injection, azacitidine, 1 mg Medicare Part B payment limit (ASP + 6%): $0.40

FDA lists these products with the same active ingredient.

0143-9606 — Azacitidine, 0781-3491 — Azacitidine, 16714-927 — Azacitidine, 16729-306 — Azacitidine, 31722-365 — Azacitidine, 43598-305 — Azacitidine, 43598-465 — Azacitidine, 43598-678 — AZACITIDINE, 43817-906 — Azacitidine, 58458-002 — Azacitidine, 59572-102 — azacitidine, 59572-730 — azacitidine, 59572-740 — azacitidine, 60505-6271 — azacitidine, 63323-771 — Azacitidine, 68001-313 — Azacitidine, 68001-527 — Azacitidine, 68001-620 — Azacitidine, 69539-112 — Azacitidine, 70069-857 — Azacitidine, +7 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.